InsiderClue
← All stocks

ANAVEX LIFE SCIENCES CORP.

AVXL Mostly scheduled
CIK 0001314052 #3627 in the set updated 22 Sep 2026
Bought (120 mo)
$113.06K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$12.27M
$0.00 on a plan · $12.27M straight out of an exercise
Sold at will
$0.00
0 of 7 sales
Net
−$12.16M
+$113.06K against sales at will

By person

6 insiders · 42 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Boenisch Sandra
PFO & Treasurer
—
$4.42M (1) scheduled
−$4.42M
22,963
0.0257%
$83.59K
0.0%
MISSLING CHRISTOPHER U
President and CEO
$54.45K (26)
$3.86M (3) scheduled
−$3.80M
1,510,165
1.69%
$5.50M
+50.5%
FAVUS ELLIOT
Director
—
$3.54M (2) scheduled
−$3.54M
0
0.0000%
$0.00
—
Skarpelos Athanasios
Director
—
$453.00K (1) scheduled
−$453.00K
1,306,458
1.46%
$4.76M
0.0%
Donhauser Peter D.O.
Director
$36.01K (4)
—
+$36.01K
5,000
0.0056%
$18.20K
—
Thomas Steffen
Director
$22.60K (1)
—
+$22.60K
43,651
0.0489%
$158.89K
—

Individual transactions

7
Insider
Date
Role
Action
Shares
Price
Amount
MISSLING CHRISTOPHER U
28 Mar 2024
President and CEO
Sold after exercise
73,380
$5.11
$374.97K
MISSLING CHRISTOPHER U
28 Jun 2023
President and CEO
Sold after exercise
268,000
$7.98
$2.14M
Skarpelos Athanasios
25 May 2022
Director
Sold after exercise
50,000
$9.06
$453.00K
Boenisch Sandra
29 Jun 2021
PFO and Treasurer
Sold after exercise
166,696
$26.53
$4.42M
MISSLING CHRISTOPHER U
29 Jun 2021
President and CEO
Sold after exercise
51,620
$26.00
$1.34M
FAVUS ELLIOT
21 May 2021
Director
Sold after exercise
145,000
$11.70
$1.70M
FAVUS ELLIOT
24 Feb 2021
Director
Sold after exercise
145,500
$12.66
$1.84M
Show all 42 transactions →

What was left out

Form 4 filings counted 118
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 7
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 2,308,590
History held since 26 Sep 2016